FENC Financial Statements

Balance sheet, income statement, cash flow, and dividends for Fennec Pharmaceuticals Inc (FENC).


$173.37M Market Cap.

As of 03/26/2025 5:00 PM ET (MRY) • Disclaimer

FENC Market Cap. (MRY)


FENC Shares Outstanding (MRY)


FENC Assets (MRY)


Total Assets

$44.95M

Total Liabilities

$50.82M

Total Investments

$0

FENC Income (MRY)


Revenue

$47.54M

Net Income

-$436.00K

Operating Expense

$41.79M

FENC Cash Flow (MRY)


CF Operations

$26.98M

CF Investing

$0

CF Financing

-$13.62M

FENC Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

FENC Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$44,946,000 (67.31%)

$26,864,000 (-0.28%)

$26,939,000 (20.19%)

$22,414,000 (-28.66%)

Assets Current

$44,124,000 (64.29%)

$26,858,000 (0.49%)

$26,728,000 (19.39%)

$22,387,000 (-28.74%)

Assets Non-Current

$822,000 (13600.00%)

$6,000 (-97.16%)

$211,000 (681.48%)

$27,000 (0%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$5,872,000 (49.48%)

-$11,622,000 (-352.39%)

-$2,569,000 (-116.29%)

$15,772,000 (-45.74%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$26,634,000 (100.72%)

$13,269,000 (-44.19%)

$23,774,000 (12.67%)

$21,100,000 (-30.46%)

Accumulated Other Comprehensive Income

$1,243,000 (0.00%)

$1,243,000 (0.00%)

$1,243,000 (0.00%)

$1,243,000 (0.00%)

Deferred Revenue

$24,809,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$1,060,000 (-50.83%)

$2,156,000 (274.31%)

$576,000 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$12,884,000 (46.18%)

$8,814,000 (470.49%)

$1,545,000 (0%)

$0 (0%)

Trade & Non-Trade Payables

$3,241,000 (-14.21%)

$3,778,000 (58.08%)

$2,390,000 (207.59%)

$777,000 (-50.54%)

Accumulated Retained Earnings (Deficit)

-$219,681,000 (-0.20%)

-$219,245,000 (-7.90%)

-$203,200,000 (-13.21%)

-$179,486,000 (-10.70%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$18,069,000 (-39.23%)

$29,735,000 (20.68%)

$24,639,000 (393.97%)

$4,988,000 (0%)

Debt Current

$2,000 (-90.48%)

$21,000 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$18,067,000 (-39.20%)

$29,714,000 (20.60%)

$24,639,000 (393.97%)

$4,988,000 (0%)

Total Liabilities

$50,818,000 (32.04%)

$38,486,000 (30.43%)

$29,508,000 (344.26%)

$6,642,000 (183.00%)

Liabilities Current

$6,919,000 (-8.39%)

$7,553,000 (63.88%)

$4,609,000 (178.66%)

$1,654,000 (-29.53%)

Liabilities Non-Current

$43,899,000 (41.92%)

$30,933,000 (24.23%)

$24,899,000 (399.18%)

$4,988,000 (0%)

FENC Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$47,538,000 (123.69%)

$21,252,000 (1284.50%)

$1,535,000 (0%)

$0 (0%)

Cost of Revenue

$3,184,000 (152.90%)

$1,259,000 (1363.95%)

$86,000 (0%)

$0 (0%)

Selling General & Administrative Expense

$41,479,000 (26.82%)

$32,708,000 (59.50%)

$20,507,000 (67.51%)

$12,242,000 (-5.47%)

Research & Development Expense

$307,000 (448.21%)

$56,000 (-98.41%)

$3,531,000 (-29.11%)

$4,981,000 (-2.43%)

Operating Expenses

$41,786,000 (27.54%)

$32,764,000 (36.30%)

$24,038,000 (39.57%)

$17,223,000 (-4.61%)

Interest Expense

$4,069,000 (19.89%)

$3,394,000 (247.03%)

$978,000 (676.19%)

$126,000 (1300.00%)

Income Tax Expense

$365,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$436,000 (97.28%)

-$16,045,000 (32.34%)

-$23,714,000 (-36.71%)

-$17,346,000 (4.21%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$436,000 (97.28%)

-$16,045,000 (32.34%)

-$23,714,000 (-36.71%)

-$17,346,000 (4.21%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$436,000 (97.28%)

-$16,045,000 (32.34%)

-$23,714,000 (-36.71%)

-$17,346,000 (4.21%)

Weighted Average Shares

$27,294,000 (2.71%)

$26,574,000 (1.14%)

$26,275,000 (1.03%)

$26,006,000 (9.71%)

Weighted Average Shares Diluted

$27,294,000 (2.71%)

$26,574,000 (1.14%)

$26,275,000 (1.03%)

$26,006,000 (9.71%)

Earning Before Interest & Taxes (EBIT)

$3,998,000 (131.60%)

-$12,651,000 (44.36%)

-$22,736,000 (-32.03%)

-$17,220,000 (4.86%)

Gross Profit

$44,354,000 (121.85%)

$19,993,000 (1279.78%)

$1,449,000 (0%)

$0 (0%)

Operating Income

$2,568,000 (120.11%)

-$12,771,000 (43.46%)

-$22,589,000 (-31.16%)

-$17,223,000 (3.70%)

FENC Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow from Financing

-$13,615,000 (-305.11%)

$6,638,000 (-67.98%)

$20,732,000 (316.47%)

$4,978,000 (-84.58%)

Net Cash Flow from Operations

$26,980,000 (257.38%)

-$17,143,000 (5.07%)

-$18,058,000 (-26.97%)

-$14,222,000 (8.80%)

Net Cash Flow / Change in Cash & Cash Equivalents

$13,365,000 (227.23%)

-$10,505,000 (-492.86%)

$2,674,000 (128.93%)

-$9,244,000 (-155.37%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

-$13,000,000 (-360.16%)

$4,997,000 (-74.93%)

$19,935,000 (298.70%)

$5,000,000 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$5,061,000 (-5.47%)

$5,354,000 (26.87%)

$4,220,000 (5.11%)

$4,015,000 (39.65%)

Depreciation Amortization & Accretion

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

FENC Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

93.30% (-0.85%)

94.10% (-0.32%)

94.40%

-

Profit Margin

-0.90% (98.81%)

-75.50% (95.11%)

-1544.90%

-

EBITDA Margin

8.40% (114.12%)

-59.50% (95.98%)

-1481.20%

-

Return on Average Equity (ROAE)

18.60% (-88.63%)

163.60% (136.73%)

-445.40% (-426.48%)

-84.60% (-22.43%)

Return on Average Assets (ROAA)

-0.70% (99.05%)

-73.60% (28.54%)

-103.00% (-54.89%)

-66.50% (-5.72%)

Return on Sales (ROS)

8.40% (114.12%)

-59.50% (95.98%)

-1481.20%

-

Return on Invested Capital (ROIC)

10.60% (123.61%)

-44.90% (74.34%)

-175.00% (68.39%)

-553.60% (-155.80%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-316 (-1589.84%)

-18.7 (-75.31%)

-10.67 (-62.43%)

-6.57 (33.01%)

Price to Sales Ratio (P/S)

3.63 (-74.13%)

14.03 (-91.46%)

164.33

-

Price to Book Ratio (P/B)

-29.52 (-14.83%)

-25.71 (73.77%)

-98.05 (-1451.44%)

7.25 (9.69%)

Debt to Equity Ratio (D/E)

-8.65 (-161.37%)

-3.31 (71.17%)

-11.49 (-2828.27%)

0.42 (419.75%)

Earnings Per Share (EPS)

-0.02 (96.67%)

-0.6 (33.33%)

-0.9 (-34.33%)

-0.67 (11.84%)

Sales Per Share (SPS)

1.74 (117.75%)

0.8 (1279.31%)

0.06 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

0.99 (253.18%)

-0.65 (6.11%)

-0.69 (-25.59%)

-0.55 (16.87%)

Book Value Per Share (BVPS)

-0.21 (50.80%)

-0.44 (-345.92%)

-0.1 (-116.17%)

0.61 (-50.57%)

Tangible Assets Book Value Per Share (TABVPS)

1.65 (62.91%)

1.01 (-1.37%)

1.02 (18.91%)

0.86 (-34.94%)

Enterprise Value Over EBIT (EV/EBIT)

41 (264.00%)

-25 (-127.27%)

-11 (-83.33%)

-6 (33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

40.73 (265.58%)

-24.6 (-126.58%)

-10.86 (-96.60%)

-5.52 (37.19%)

Asset Turnover

0.81 (-17.44%)

0.97 (1355.22%)

0.07 (0%)

0 (0%)

Current Ratio

6.38 (79.33%)

3.56 (-38.68%)

5.8 (-57.16%)

13.54 (1.11%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$26,980,000 (257.38%)

-$17,143,000 (5.07%)

-$18,058,000 (-26.97%)

-$14,222,000 (8.80%)

Enterprise Value (EV)

$162,831,719 (-47.67%)

$311,172,065 (26.07%)

$246,818,170 (159.58%)

$95,082,153 (-40.24%)

Earnings Before Tax (EBT)

-$71,000 (99.56%)

-$16,045,000 (32.34%)

-$23,714,000 (-36.71%)

-$17,346,000 (4.21%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$3,998,000 (131.60%)

-$12,651,000 (44.36%)

-$22,736,000 (-32.03%)

-$17,220,000 (4.86%)

Invested Capital

$29,462,000 (-17.65%)

$35,777,000 (54.24%)

$23,195,000 (399.03%)

$4,648,000 (464.84%)

Working Capital

$37,205,000 (92.72%)

$19,305,000 (-12.72%)

$22,119,000 (6.68%)

$20,733,000 (-28.68%)

Tangible Asset Value

$44,946,000 (67.31%)

$26,864,000 (-0.28%)

$26,939,000 (20.19%)

$22,414,000 (-28.66%)

Market Capitalization

$173,371,719 (-41.99%)

$298,841,065 (18.64%)

$251,882,170 (120.12%)

$114,430,153 (-40.49%)

Average Equity

-$2,346,500 (76.07%)

-$9,804,750 (-284.14%)

$5,324,500 (-74.03%)

$20,499,750 (-21.79%)

Average Assets

$59,055,250 (171.05%)

$21,787,500 (-5.35%)

$23,018,250 (-11.78%)

$26,092,000 (-9.38%)

Invested Capital Average

$37,613,250 (33.53%)

$28,168,250 (116.80%)

$12,992,500 (317.70%)

$3,110,500 (270.49%)

Shares

27,432,234 (2.99%)

26,634,676 (1.51%)

26,237,726 (0.89%)

26,006,853 (0.76%)